- Home
- PRTA vs TALK Comparison
PRTA vs TALK Comparison
Compare PRTA & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- TALK
- Stock Information
- Founded
- PRTA 2012
- TALK 2012
- Country
- PRTA Ireland
- TALK United States
- Employees
- PRTA N/A
- TALK N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- TALK Medical/Nursing Services
- Sector
- PRTA Health Care
- TALK Health Care
- Exchange
- PRTA Nasdaq
- TALK Nasdaq
- Market Cap
- PRTA 472.1M
- TALK 442.1M
- IPO Year
- PRTA N/A
- TALK N/A
- Fundamental
- Price
- PRTA $9.92
- TALK $2.76
- Analyst Decision
- PRTA Buy
- TALK Buy
- Analyst Count
- PRTA 9
- TALK 6
- Target Price
- PRTA $13.14
- TALK $4.50
- AVG Volume (30 Days)
- PRTA 785.0K
- TALK 1.5M
- Earning Date
- PRTA 11-11-2025
- TALK 10-30-2025
- Dividend Yield
- PRTA N/A
- TALK N/A
- EPS Growth
- PRTA N/A
- TALK N/A
- EPS
- PRTA N/A
- TALK 0.02
- Revenue
- PRTA $10,341,000.00
- TALK $202,611,000.00
- Revenue This Year
- PRTA N/A
- TALK $22.35
- Revenue Next Year
- PRTA $602.32
- TALK $21.66
- P/E Ratio
- PRTA N/A
- TALK $162.29
- Revenue Growth
- PRTA N/A
- TALK 17.43
- 52 Week Low
- PRTA $4.32
- TALK $2.22
- 52 Week High
- PRTA $18.88
- TALK $4.36
- Technical
- Relative Strength Index (RSI)
- PRTA 55.31
- TALK 49.02
- Support Level
- PRTA $9.98
- TALK $2.88
- Resistance Level
- PRTA $10.90
- TALK $3.10
- Average True Range (ATR)
- PRTA 0.47
- TALK 0.16
- MACD
- PRTA -0.06
- TALK 0.00
- Stochastic Oscillator
- PRTA 23.93
- TALK 17.05
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.